Medifirst Solutions 10-K 12 Apr 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Apr. 11, 2018	Jun. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Medifirst Solutions, Inc.
Entity Central Index Key	1,522,704
Trading Symbol	MFST
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 1,366,829
Entity Common Stock, Shares Outstanding		1,243,548,268

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current Assets:
Cash	$ 287,569	$ 165,017
Inventory	33,435	14,023
Prepaid items		15,720
Total current assets	321,004	194,760
Property, Plant and Equipment, net	1,232	1,871
Other Assets
Security Deposit	650	650
Intangible Asset -License Agreement, net	116,252	137,502
Total other assets	116,902	138,152
Total Assets	439,138	334,783
Liabilities
Accounts payable and accrued expenses	97,621	75,368
Accrued expenses - officer's compensation	401,079	405,197
Due to related party	8,921	8,921
Loans payable - stockholders	14,499	10,555
Note Payable for license agreement		150,000
Convertible notes payable	280,351	391,653
Convertible notes payable-related party	133,750
Derivative Liabilities	251,886	144,792
Total current liabilities	1,188,107	1,186,486
Commitments & Contingencies (Note 8)
Stockholders' Equity:
Common stock, $0.0001 par value; 4,000,000,000 shares authorized, 849,437,003 and 225,847,976 shares issued and outstanding, respectively	84,946	22,586
Additional paid in capital	2,831,163	1,232,996
Accumulated deficit	(3,665,129)	(2,107,293)
Total Stockholders' Equity	(748,969)	(851,703)
Total Liabilities & Stockholders' Equity	439,138	334,783
Series A preferred stock
Stockholders' Equity:
Preferred stock	50	5
Series B convertible preferred stock
Stockholders' Equity:
Preferred stock	$ 1	$ 3

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	4,000,000,000	4,000,000,000
Common stock, shares issued	849,437,003	225,847,976
Common stock, shares outstanding	849,437,003	225,847,976
Series A preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	50,000	50,000
Series B convertible preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	8,000	26,100
Preferred stock, shares outstanding	8,000	26,100

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Statements of Operations [Abstract]
Product sales, net	$ 29,995
Total Revenues	29,995
Cost of goods sold	1,058
Gross income	28,937
Expenses:
Officer's compensation	112,500	100,000
Impairment loss- inventory		45,475
Advertising and promotion	63,548	48,694
Computer and internet	4,130	978
Consulting fees	435,589	295,764
Professional fees	224,286	143,531
Rent	20,713	9,536
Travel	12,903	3,959
Lab testing	7,107	32,449
Dues and subscriptions	3,720	11,402
Other	96,012	41,958
Total Expenses	980,508	733,746
Net loss from Operations before other income, expenses	(951,571)	(733,746)
Other income and (expense)
Interest expense	(405,144)	(641,812)
Interest income		1
Loss on extinguishment of debt		(4,733)
Change in fair value -derivatives	(201,121)	242,606
Net loss before provision for income tax	(1,557,836)	(1,137,684)
Provision for income taxes
Net Loss	$ (1,557,836)	$ (1,137,684)
Loss per common share - Basic and fully diluted	$ 0	$ (0.01)
Weighted average number of shares outstanding - Basic and fully diluted	551,555,582	80,655,915

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($)	Total	Preferred Class A	Preferred Class B	Common Stock	Additional Paid in Capital	Accumulated Deficit
Balance at Dec. 31, 2015	$ (655,911)			$ 3,510	$ 310,183	$ (969,609)
Balance, shares at Dec. 31, 2015		50,000		35,101,750
Issuance of common shares upon conversions of notes payable	292,254			$ 13,311	278,943
Issuance of common shares upon conversions of notes payable, shares				133,096,226
Issuance of common shares for services rendered	269,990			$ 5,090	264,900
Issuance of common shares for services rendered, shares				50,900,000
Issuance of Series B Preferred shares as part consideration for license agreement	3		$ 3
Issuance of Series B Preferred shares as payment for inventory	50,000		$ 1		49,999
Issuance of Series B Preferred shares as payment for inventory, shares			10,000
Issuance of Series B Preferred shares as consideration for trademark purchase	19,999				19,999
Issuance of Series B Preferred shares as consideration for trademark purchase, shares			4,000
Additional paid in capital from conversion of accrued interest on notes	2,836				2,836
Issuance of common shares to extend due date of a note payable at par value per share	30			$ 30
Issuance of common shares to extend due date of a note payable at par value per share, shares				300,000
Issuance of common shares upon conversion of Series B Preferred Stock	(1)		$ (1)	$ 645	(645)
Issuance of common shares upon conversion of Series B Preferred Stock, shares			(12,900)	6,450,000
Additional paid in capital from derivative liability on debt conversion	306,781				306,781
Net Loss	(1,137,684)					(1,137,684)
Balance at Dec. 31, 2016	(851,703)			$ 22,586	1,232,996	(2,107,293)
Balance, shares at Dec. 31, 2016		50,000	26,100	225,847,976
Issuance of common shares upon conversions of notes payable	547,748			$ 42,655	505,093
Issuance of common shares upon conversions of notes payable, shares				426,539,027
Issuance of common shares for services rendered	492,980			$ 18,800	474,180
Issuance of common shares for services rendered, shares				188,000,000
Issuance of Series B Preferred shares as part consideration for license agreement, shares			25,000
Issuance of Series A Preferred Stock	45	$ 45
Issuance of Series A Preferred Stock, shares		450,000
Issuance of common shares upon conversion of Series B Preferred Stock			$ (2)	$ 905	903
Issuance of common shares upon conversion of Series B Preferred Stock, shares			(18,100)	9,050,000
Additional paid in capital from derivative liability on debt conversion	617,991				617,991
Net Loss	(1,557,836)					(1,557,836)
Balance at Dec. 31, 2017	$ (748,969)			$ 84,946	$ 2,831,163	$ (3,665,129)
Balance, shares at Dec. 31, 2017		500,000	8,000	849,437,003

Consolidated Statement of Stoc6

Consolidated Statement of Stockholders' Equity (Parenthetical)	12 Months Ended
	Dec. 31, 2017shares
Statement of Stockholders' Equity [Abstract]
Issuance of Series A preferred stock	450,000
Issuance of common shares upon conversion of Series B preferred stock	18,100

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (1,557,836)	$ (1,137,684)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation & amortization expense	21,890	13,430
Stock Based Compensation	493,025	270,020
Impairment loss- inventory		45,475
Change in assets and liabilities
Security deposit		(650)
Accounts payable and accrued expenses	84,811	63,798
Change in fair value - derivatives	201,121	(242,606)
Amortization of debt discount & other financing costs	321,983	665,385
Stockholder's loan		(13,894)
Prepaid expenses	15,720	(15,720)
Inventory	(19,412)	(9,498)
Net cash used by operating activities	(438,698)	(361,944)
Cash flows from investing activities:
Purchase of equipment		(642)
Net cash used by investing activities		(642)
Cash flows from financing activities:
Proceeds from stockholder loan	5,000
Proceeds from sale of Convertible notes payable	556,250	370,645
Net cash provided by financing activities	561,250	370,645
Net increase (decrease) in cash	122,552	(8,059)
Cash at beginning of period	165,017	156,958
Cash at end of period	287,569	165,017
Cash paid during the period for:
Interest
Income taxes	1,826	1,014
Non-cash investing and financing activities:
Common stock issued for convertible debt	5,230	99,387
Derivative liability extinguished upon conversion	617,990
Common stock issued for convertible debt with derivatives	544,323	636,711
New discounts associated with derivatives on convertible debt	505,607
Accounts Payable exchanged for promissory note	15,000
Preferred stock issued for debt settlement and license agreement		70,001
Preferred stock exchanged for common stock	$ 905

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Medifirst Solutions, Inc. (“MSI” or the “Company”) was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company’s products, developing the Company’s models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company’s offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. The company has started to hire a salesforce and sign distribution agreements in anticipation of future sales. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Company is actively putting together a sales and distribution team to offer our lasers in the US and foreign markets. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company’s president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. (“MLM”) with the total purchase price of 20,000 shares of the Company’s common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology. Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, all adjustments considered necessary for a fair presentation of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior year net income or shareholders’ equity. Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company’s historical return experience. Revenue is presented net of returns. Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management’s estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of December 31, 2017 or December 31, 2016. There are no customer account receivables as of December 31, 2017 or December 31, 2016. Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Finished goods inventory includes hand held laser devices, their carrying cases and goggles. Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years. Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company’s wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in 2015. Intangible Asset- Licensing Agreement On March 8 th - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000,000 shares of the Company’s common stock. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet since they are based on sales for which the company has had only minimum thus far. The licensing agreement is for a ten year period effective from October 1, 2015. The cost of the licensing agreement is being amortized over it’s ten-year period and charged to income on a straight-line basis. Debt Issue Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements). Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values. Segment Information The Company follows Accounting Standards Codification (“ASC”) 280, “Segment Reporting”. The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. As of December 31, 2017, the convertible notes payable can be converted into approximately 1,039,477,572 shares of common stock. Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of December 31, 2017 and does not expect this to change significantly over the next 12 months. Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2017, the Company had $287,569 in cash equivalents. Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company to annual reporting periods beginning after December 15, 2017 (that is, a public organization is required to apply the new revenue standard beginning in the first interim period within the year of adoption). Additionally, the Board decided to permit public organizations to adopt the new revenue standard early, but not before the original public organization effective date (that is, annual periods beginning after December 15, 2016). A public organization should apply the new revenue standard to all interim reporting periods within the year of adoption. The Company has evaluated the impact of this ASU on the consolidated financial statements and has determined, at this time, the ASU’s implementation would not have a material impact on revenue recognition. See below - Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In April 2016, the FASB issued Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: 1. Identify the contract(s) with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when (or as) the entity satisfies a performance obligation. The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The Company is currently evaluating the impact of this ASU on the consolidated financial statements.

Property, Plant and Equipment (

Property, Plant and Equipment (Net)	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment (Net) [Abstract]
PROPERTY, PLANT AND EQUIPMENT (NET)	Note 2. PROPERTY, PLANT AND EQUIPMENT (NET) Equipment is recorded at cost and consisted of the following at December 31, 2017 and December 31, 2016: December 31, 2017 December 31,2016 Computer equipment $ 8,956 $ 8,956 Less: accumulated depreciation (7,725 ) (7,085 ) $ 1,232 $ 1,871 Depreciation expense was $640 and $930, for the years ended December 31, 2017 and 2016 respectively.

Due to Related Party

Due to Related Party	12 Months Ended
	Dec. 31, 2017
Due to Related Party [Abstract]
DUE TO RELATED PARTY	Note 3. DUE TO RELATED PARTY The Company was indebted to a related party through common management in the amount of $8,921 at December 31, 2017 and December 31, 2016, respectively. The loan bears no interest and is payable on demand. See Note 10 for additional related party transactions.

Loans Payable - Stockholders

Loans Payable - Stockholders	12 Months Ended
	Dec. 31, 2017
Loans Payable - Stockholders [Abstract]
LOANS PAYABLE - STOCKHOLDERS	Note 4. LOANS PAYABLE - STOCKHOLDERS During the periods ended December 31, 2017 and 2016 a stockholder of the Company advanced the Company $-0- and $-0- respectively. The loan has a balance of $8,398 at December 31, 2017 and December 31, 2016, respectively. The loan bears no interest and is payable on demand. In December 2012, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at 10% per annum. Principal and interest were due and payable on June 2, 2013. In April 2014, the note was amended to provide the note holder with the option to convert the note to the Company’s common stock at $0.0001 per share. Subsequently, in 2014, in a private transaction, the note holder transferred $2,500 of note principal to third parties and the new holders converted their holdings into 2,500,000 shares of the Company’s common stock. During 2015, the original note holder transferred an additional $2,400 of note principal to third parties who converted their holdings into 2,400,000 shares of the Company’s common stock. At December 31, 2017 and December 31, 2016, the loan had balance was $100 and $100, respectively. At December 31, 2017 and December 31, 2016, the Company was indebted to a stockholder in the amount of $1,000 and $1,500, respectively. The loan has an interest rate of 26.7%. In February 2017 the note was sold to another investor and that noteholder converted $500 in principal into 5,000,000 shares of common stock. Principal and accrued interest were due and payable on January 1, 2014. In February 2016, the Company issued a promissory note to a stockholder in the amount of $7,000 with interest at the rate of 6% per annum. On September 6, 2016 the note holder converted the entire principal balance and accrued interest into common stock and therefore at December 31, 2017 there is no principal balance remaining on the note. In March 2017, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at the rate of 9% per annum. The note matures on April 1, 2018. As of December 31, 2017 the entire $5,000 principal balance is outstanding on this note.

Convertible Notes Payable

Convertible Notes Payable	12 Months Ended
	Dec. 31, 2017
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 5. CONVERTIBLE NOTES PAYABLE Note Payable-BS In March 2011, the Company issued $800 aggregate principal amount of 6% convertible notes due in January 2012. Interest on the notes accrue at the rate of 6% per annum and are payable when the notes mature. The notes matured prior to conversion but have not been repaid. Interest continues to accrue at the rate of 6% per annum. The holder of one of the notes converted $110 of note principal into 1,100,000 shares of common stock as follows: Principal Amount Converted Conversion Rate Shares Received Date of Conversion June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000 In August 2013, in a private transaction, the same note holder transferred $330 of the remaining note principal plus $55 in accrued interest to a third party. In August 2013, in a private transaction, the new note holder transferred $5 of the remaining note principal to a third party who then converted the note into 50,000 shares of common stock. In September 2013, the new note holder converted $100 of note principal into 1,000,000 shares of common stock. In September 2013, in a private transaction, the new note holder transferred $35 of the remaining note principal to a third party who then converted the note into 350,000 shares of common stock. In November and December 2013, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000 In March and April 2014, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000 Subsequent to these conversions there remains $125 in note principal outstanding at December 31, 2017. Note Payable-SF In July 2013, the holder of the second note converted $240 of note principal into 400,000 shares of the Company’s common stock at $0.0006 per share. At December 31, 2017 and December 31 2016, the note had a remaining principal balance of $60 and $60, respectively. At any time on or after the maturity date, the holders of the notes, have the option of converting any of the unpaid principal and interest into the Company’s common stock. The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 84,858,757 shares at December 31, 2017 and 22,562,213 shares at December 31, 2016. Note Payable-RK In May 2012, the Company issued a $25,000 6% per annum note that matured in November 2012. In December 2012 the note was amended to be a convertible note. Interest on the note accrues interest at 6% per annum and is payable when the note matures. The holder of the $25,000 note had the option of converting it at any time prior to maturity. The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock. The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: Principal Amount Converted Conversion Rate Shares Received Date of Conversion December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000 In July 2013, the Company retired $14,000 of note principal in payment for consulting services provided to the note holder. In July 2013, the note holder converted $300 of note principal into 300,000 shares of the Company’s common stock. In July 2013, in a private transaction, the note holder transferred the remaining note principal balance of $9,690 to a third party (See Note Payable-NW Note Payable-NW After receiving the transfer of the principal balance of $9,690 in July 2013 in the private transaction noted in Note Payable-RK In October 2013, the note holder converted $400 of note principal into 400,000 shares of the Company’s common stock at $0.001 per share. In October 2014, the note holder converted $1,100 of note principal into 1,100,000 of the Company’s common stock. The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 84,858,757 shares at December 31, 2017 and 22,562,213 shares at December 31, 2016. In August 2016, the note holder converted $3,000 of note principal into 3,000,000 shares of the Company’s common stock. At December 31, 2017 and December 31, 2016, the remaining principal balance on this portion of the note is $715 and $715 respectively. Note Payable-MC #1 In August 2013, the note holder/stockholder who received the $4,475 in principal from the aforementioned noteholder, converted $700 of note principal into 700,000 shares of the Company’s common stock at $0.001 per share. In October 2013, in a private transaction, this note holder transferred $1,000 of note principal to a third party of which $700 was converted into 700,000 shares in June 2014. In January 2017 the remaining $2,075 principal balance on this note was transferred to another investor who during the same period converted the entire remaining principal balance into 4,190,480 common shares. Note Payable-MC #2 In April 2015, the Company issued a $3,000 8% per annum note that matures in October 2015. The holder of the note has the right to convert the principal into shares of the Company’s common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures. During January 2017, the current noteholder converted $1,100 in principal balance into 11,000,000 shares of common stock. During the same period, the current noteholder transferred $600 of the remaining principal balance to another investor who then converted the entire principal balance he received into 6,000,000 shares of common stock. During April 2017, the current noteholder converted $410 of remaining principal into 6,000,000 shares of common stock. There remains $890 in principal balance at December 31, 2017 with the current noteholder and $3,000 in principal balance with the original noteholder at December 31, 2016. Convertible Note Payable-VV to LG (8%)#1 In July 2015, the Company issued a convertible note payable in the principal amount of $59,000. The note matured in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company’s common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at December 31, 2017 and December 31, 2016. Convertible Note Payable-VV (8%) #2 In August 2015, the Company issued a convertible note payable in the principal amount of $38,000. The note matured in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company’s common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at December 31, 2017 and December 31, 2016. Convertible Note Payable-LGC(8%) On October 8, 2015, the Company issued a convertible note payable in the principal amount of $31,000 with an Original Issue Discount of $1,500. The note matures on October 8, 2016 and bears interest at 8%. The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at December 31, 2017 and December 31,2016. Debenture Payable - (5%) B (Original $100K) In June 2015, the Company issued a convertible note payable in the principal amount of $100,000. The note matures in December 2015 and bears interest at 5%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company’s common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. The remaining principal balance on the note at June 30, 2016 was $40,000 after a private sale of $60,000 in principal and deemed accrued interest on May 2, 2016 to another investor and the issuance of a replacement note by the Company - see below- Convertible Note Payable-SO-B (8%) (Original $60k). On September 27, 2016 the remaining $40,000 in principal balance and accrued interest on the note was sold in a private transaction to another investor and the Company issued a replacement note in the amount of $50,000. Both of the above noted transactions which took place on May 2, 2016 and September 27, 2016 respectively, resulted in a loss on the extinguishment of the original debt in the amount of $4,733 from deeming accrued interest in excess of actual accruals. This loss is reported in the statement of operations for the year ended December 31, 2016. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at December 31, 2017 and December 31,2016. As a result of the aforementioned transactions and conversions, there is no principal balance remaining on the original $100,000 note as of December 31, 2017 and December 31,2016. Convertible Note Payable-SO-B (8%) (Original $60k) On May 2, 2016, the Company issued to an Investor a replacement redeemable convertible note in the principal amount of $60,000 (“the Replacement Note”). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. Any unamortized original issue discount and deferred financing costs from the original note was expensed upon replacement. The derivative discount and liability on the original note was appropriately accounted for upon replacement and a new derivative discount and liability for the replacement note appropriately recorded. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at December 31,2016. Convertible Note Payable-CB (5%) (Original $35k) On October 15, 2015 the Company issued a convertible note payable in the principal amount of $35,000 with an Original Issue Discount of $5,000. The note matures on October 15, 2016 and bears interest at 5%. The note holder has the right at any time on or after the day that is six months from October 15, 2015 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock at the discounted rate of 55% of the lowest market trading prices during the 20 days prior to the conversion date. During the months of May, June and July 2016, the holder of the above $35,000 Note converted all of the principal to common stock thereby leaving no principal balance payable on the note as of December 31, 2017 and December 31, 2016. Convertible Note Payable-LGC (8%) On January 7 2016, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of convertible redeemable notes in aggregate principal amount of $251,803. On January 7, 2016, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the “$105K Note”); and (ii) a convertible redeemable note in principal amount of $50,000 (the “$50K Note” and together with the $105K Note, the “Notes”). Under the Purchase Agreement, on March 15, 2016 and June 15, 2016, the Company and the Investor conducted additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $50,000 and $46, 803, respectively (see Convertible Notes Payable-LGC (8%) BEN Convertible Notes Payable-LGC (8%) BEN In consideration for the issuance of the $105K Note, on January 13, 2016, the Company received net proceeds (after deducting the original issue discount and legal fees) in the amount of $75,697. In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the “Investor Note”), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016. The Notes, which are due on January 7, 2017, bear interest at the rate of 8% per annum. Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on the Notes is convertible into shares of the Company’s common stock (“Common Stock”) at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading-day period prior to conversion. In accordance with the terms of the Purchase Agreement, the investor and the Company closed on the two outstanding notes ($50,000 and $46,803) in May and June 2016 when the Company received the cash funding. During April 2017 the noteholder converted the entire principal balance of the $50,000 note into common stock of the Company. During June 2017 the noteholder converted $16,000 of the remaining principal of the $46,803 note into common stock of the Company. In July and September 2017 the noteholder converted the remaining $30,803 of the note’s principal balance into common stock. As a result, there is no principal balance remaining on either note as of December 31, 2017. As of December 31, 2016 the entire principal balances of $50,000 and $46,803 were outstanding. Convertible Notes Payable-SO (8%) On May 2, 2016, the Company issued to an Investor a convertible redeemable note in the principal amount of $57,750 (“the Note”). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. The note contains a 10% original issue discount. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. During the quarter ended March 31, 2017 the noteholder converted $32,298 of the principle balance into 23,489,690 shares of common stock thereby leaving a principal balance of $25,452 on the note at December 31, 2017. The entire principal balance in the amount of $57,750 was outstanding on the note at December 31, 2016. Convertible Notes Payable-LG (9%) On October 11, 2016, the Company issued to an Investor a replacement convertible note in the principal amount of $50,000 (“the Replacement Note”). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000. During the quarter ended December 31, 2016 the noteholder converted the entire principal balance into shares of common stock thereby leaving $-0- principal balance remaining on the note as of December 31, 2017 and December 31, 2016. Convertible Notes Payable-BBCG (9%) On October 11, 2016, the Company issued to an Investor a convertible note in the principal amount of $157,895 (“the Note”). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. The note contains an original issue discount in the amount of $7,895. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 57.5% of the lowest trading price for the twenty prior trading days including the date of conversion. During April and June of 2017, the noteholder converted the entire remaining principal balance of the note into common stock of the Company. There is no principal balance remaining on the note as of December 31, 2017. The entire $157,895 principal balance was outstanding on the note as of December 31, 2016. Convertible Notes Payable - Funding (8%) On May 1 2017, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of 8 convertible redeemable notes in aggregate principal amount of $1,012,500. On May 1st, 2017 and June 2, 2017, the Company and the Investor conducted the first two closings under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $131,250 (the “$131K Note”) ; and (ii) a convertible redeemable note in principal amount of $125,000 (the “$125K Note”). On July 10, 2017 and August 7, 2017, the Company and the Investor conducted the second two closings under the Purchase Agreement, pursuant to which the Company issued to the Investor two convertible redeemable notes each in the principal amount of $125,000; Under the Purchase Agreement, on January 1, 2018, February 2, 2018, March 10, 2018 and April 7, 2018 the Company and the Investor expected to conduct additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $131,250, $125,000, $125,000 and $125,000 respectively (the “back-end notes”). However, all these “back-end notes” were cancelled in early 2018 and will not fund. According, all the “back-end” notes were removed from the books at December 31, 2017 along with the associated investor notes receivable. In addition, all previously accrued interest expense and interest income has been removed on these “back-end notes” for the period ended December 31, 2017. In consideration for the issuance of the $131K Note and the $125K Note, on May 1, 2017 and June 2, 2017 and for the two $125k Notes on July 10, 2017 and August 7, 2017, the Company received net proceeds (after deducting $25,000 in legal fees) in the amount of $481,250. In consideration for the issuance of the $131K and the three $125k Notes, the Investor issued to the Company a $131,250 fully-collateralized secured promissory note and three $125,000 fully-collateralized secured promissory notes (the “Investor Notes”), pursuant to which the Investor agreed to pay the Company $131,250 and $375,000 on or before January 1, 2018, February 2, 2018, March 10, 2018 and April 7, 2018 respectively. These Notes (often referred to as “back-end Notes”), bear interest at the rate of 8% per annum. However, all these “back-end notes” were cancelled in early 2018 and will not fund. According, all the “back-end” notes were removed from the books at December 31, 2017 along with the associated investor notes receivable. In addition, all previously accrued interest expense and interest income as been removed on these “back-end notes” for the period ended December 31, 2017. The two notes issued May 1, 2017 ($131,250) and June 2, 2017 ($125,000) became convertible on October 28, 2017 and December 4, 2017 respectively and required derivative treatment at that time. The embedded derivative was bifurcated and accounted for separately along with the derivative discount. The derivative liability is marked-to-market each quarter with the resulting gain or loss valuation being reported in the statement of operations. During the quarter ended December 31, 2017 (after the six-month waiting period) the holder of the original note in the principal amount of $131,250 converted $21,500 and $15,350 of the note’s principal balance into 35,0358,103 and 39,713,817 shares of the Company’s common stock, respectively. The principal balance remaining on this convertible note is $94,400 as of December 31,2017. Convertible Notes Payable - JR (5%) On August 2, 2017 the Company issued a convertible note payable (promissory note) to an investor in the principal amount of $50,000. The note matures on August 2, 2018 and bears interest at 5%. The note holder has has the right at any time on or after the day that is six months from August 2, 2018 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock at a fixed price of .003 per share. The entire principal balance of $50,000 is outstanding as of December 31, 2017 Convertible Notes Payable - MLM (10%) As more fully described in Note 1 to the financial statements, on March 8th 2016 (with an effective date of October 1, 2015), the company, through it’s sole wholly-owned subsidiary (“Licensee”), entered into a Product and Know-How License Agreement (“Agreement”) with a Florida Corporation (“Licensor”) which is owned by a related party - the son of the Company’s CEO. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. During the quarter-ended June 30, 2017, $18,986 in accrued interest was satisfied through the issuance of 17,272,727 shares of the Company’s common stock. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. At such time the Note was valued with its embedded derivative and discount. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000,000 shares of the Company’s common stock leaving a balance on the note of $133,750 at December 31, 2017. The Company’s convertible notes payable and the related derivative liabilities, derivative discount, deferred financing costs and original-issue discount are presented in the financial statements at December 31, 2017 as follows: Remaining Original Deferred Total Convertible 12/31/2017 Principal Issue Derivative Financing Notes Derivative Debt Amount Discount Discount Costs Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - SD 15,000 15,000 Note Payable - NW 715 715 Note Payable - MC #2 890 890 Convertible Note Payable - JR (5%) 50,000 50,000 Convertible Note Payable - CB (5%) - - 832 Convertible Notes Payable- SO (8%) 25,452 25,452 24,925 Convertible Note Payable - LGC (8%) 1 94,400 (59,267 ) (317 ) 34,816 52,989 Convertible Note Payable - LGC (8%) 2 125,000 (83,380 ) (2,072 ) 39,548 64,458 Convertible Note Payable - LGC (8%) 3 125,000 (3,271 ) 121,729 Convertible Note Payable - LGC (8%) 4 125,000 (3,750 ) 121,250 Convertible Note Payable - MLM (10%) 133,750 (129,234 ) 4,516 108,682 $ 695,392 $ - $ (271,881 ) $ (9,410 ) $ 414,101 $ 251,886 As of December 31, 2017, the convertible notes payable can be converted into approximately 1,039,477,572 shares of common stock.

Derivatives and Fair Value Inst

Derivatives and Fair Value Instruments	12 Months Ended
	Dec. 31, 2017
Derivatives and Fair Value Instruments [Abstract]
DERIVATIVES AND FAIR VALUE INSTRUMENTS	Note 6. DERIVATIVES AND FAIR VALUE INSTRUMENTS The Company applied paragraph 815-10-05-4 of the FASB Accounting Standards Codification to the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016 and the 9% Convertible Note payable issued October 1, 2016. Based on the guidance in paragraph 815-10-05-4 of the FASB Accounting Standards Codification the Company concluded these instruments were required to be accounted for as derivatives on issuance date. The Company records the fair value of the Convertible Notes Payable and certain warrants that are classified as derivatives on issuance date and the fair value changes on each reporting date reflected in the consolidated statements of operations as “Change in Fair Value - derivatives.” These derivative instruments are not designated as hedging instruments under paragraph 815-10-05-4 of the FASB Accounting Standards Codification and are disclosed on the balance sheet under Derivative Liabilities. The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepayments and other current assets, accounts payable, and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016 and May 1, 2017 and June 2, 2017 and the 9% Convertible Note payable issued October 1, 2016, for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. We have valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a valuation consultant, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of issuance and December 31, 2017. The primary assumptions include: projected annual volatility of 122%-165%; the follow-on securities purchase option; the conversion feature as a percentage of Market; automatic/conditional conversions; market price trigger events. As of December 31, 2017 the Company’s derivative financial instruments included: 1) Embedded derivatives associated with certain of the Company’s unsecured convertible notes payable. The Company’s 5% convertible notes payable and 8% convertible notes payable and 9% convertible note payable issued to unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument. The embedded derivative feature has been bifurcated from the debt host contract, referred to as the Derivative Liability, which resulted in a reduction of the initial carrying amount (as unamortized discount) of the Convertible Notes Payable. The unamortized discount is amortized to interest expense using the effective interest method over the life of the Notes. The embedded derivative feature includes the conversion feature within the notes and an early redemption option. The compound embedded derivatives within the convertible notes have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company’s statement of operations as Change in fair value of derivative liabilities. The 5% Convertible Note Payable and the 8% Convertible Notes Payable and the 9% convertible note payable are valued at December 31, 2017. The following assumptions were used for the valuation of the embedded derivative: - The stock price of $0.0015 decreased to $0.0006 in this period (basis for the variable conversion price) would fluctuate with the Company projected volatility; - An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; - Capital raising events (a single financing at 1 month from the valuation date) are a factor for the VV Convertible Note. The full reset events projected to occur based on future stock issuance (single event) resulting in a reset exercise price. - The monthly trading volume would average $569,722 (rounded) as of 12/31/2017 and would increase at 5% per month; ownership limits conversion across LG’s 6 notes based on 4.99% with shares outstanding increasing monthly by 1%. - The variable conversion price of 50% to 58% over 3 to 20 trading days would have effective rates of 42.38% to 52.78%; - The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default; - The projected annual volatility for each valuation period was based on the historical volatility of the company: 9/30/2017 165 % 10/28/2017 142 % 11/2/2017 131 % 12/4/2017 132 % 12/18/2017 122 % 12/31/2017 125 % The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuation. The Company’s derivative liabilities on convertible notes payable are presented at market value in the financial statements at December 31, 2017 as follows: 12/31/2017 Convertible Note Derivative Treatment Maturity Date Principal Note Amount Original Derivative Valuation Derivative Valuation December 31, Quarter Ended March 31, 2017 Issuances Quarter Ended Derivative Valuation March 31, Quarter Quarter Ended Derivative Quarter Quarter Ended 2017 Mark-to-Market Derivative Quarter Quarter Ended Derivative 8% Convertible Note Payable- issued 5/2/2016 10/1/2016 5/2/2017 $ 57,750 $ 58,355 $ 58,355 - $ (34,680 ) $ 17,806 $ 41,481 $ - $ (14,925 ) $ 26,556 $ - $ - $ (821 ) $ 25,735 $ (810.00 ) $ 24,925 5% Convertible Notes Payable-issued 6/12/2015 4/12/2016 1/7/2017 35,863 37,827 918 440 $ 1,358 - (475 ) 883 (18 ) 865 $ (33.00 ) 832 9% Convertible Notes Payable-issued 10/01/2016 3/26/2017 3/27/2018 157,895 56,956 162,463 58,370 $ 220,833 (194,820 ) - (26,013 ) - - - 8% Convertible Notes Payable-issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 21,395 (136,759 ) 115,364 $ - - - - - - 8% Convertible Notes Payable-issued January 7, 2016 1/7/2016 1/7/2017 50,000 15,803 15,803 66,985 $ 82,788 (85,228 ) - 2,440 - - - 8% Convertible Notes Payable-issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 36,449 45,348 $ 81,797 (74,602 ) - (7,195 ) - - - 8% Convertible Notes Payable-issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 15,894 60,672 $ 76,566 (17,111 ) - (26,546 ) 32,909 (31,741 ) (1,168 ) - - 8% Convertible Notes Payable-issued May 1, 2016 10/28/2017 5/1/2018 131,250 103,294 - (28,820 ) 103,294 (21,485 ) 52,989 8% Convertible Notes Payable-issued June 7, 2016 12/4/2017 6/7/2018 125,000 90,596 - 90,596 (26,138 ) 64,458 10% Convertible Notes Payable-issued March 8, 2016 9/15/2017 9/8/2018 150,000 167,164 - (17,805 ) 167,164 3,120 152,479 $ (43,797.00 ) 108,682 $ 909,561 $ 786,935 $ 148,814 $ 162,463 $ (171,439 ) $ 364,985 $ 504,823 $ (371,761 ) $ - $ (72,714 ) $ 60,348 $ (49,546 ) $ 167,164 $ 1,113 $ 179,079 $ (28,820 ) $ 193,890 $ (92,263 ) $ 251,886 The Company’s total mark-to-market fair value adjustment ((income)/expense) for the year ended December 31, 2017 amounted to $201,121 as follows: Mark-to market fair value adjustment for the quarter ended March 31, 2017 $ 364,985 Mark-to market fair value adjustment for the quarter ended June 30, 2017 $ (72,714 ) Mark-to market fair value adjustment for the quarter ended September 30, 2017 $ 1,113 Mark-to market fair value adjustment for the quarter ended December 31, 2017 $ (92,263 ) Total mark-to market fair value adjustment for the year ended December 31, 2017 $ 201,121

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2017
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	Note 7. STOCKHOLDERS’ EQUITY The Company has authorized 4,000,000,000 shares of common stock with a par value of $0.0001 per share. Effective September 19, 2017, the Company amended its Articles of Incorporation to increase its authorized Common Stock to 4,000,000,000 shares. There were 849,437,003 and 225,847,976 shares of common stock issued and outstanding at December 31, 2017 and December 31, 2016, respectively. The Company has authorized 1,000,000 shares of Series A preferred stock with a par value of $0.0001 per share. At September 30, 2017 and December 31, 2016, there were 500,000 shares and 50,000 shares of Series A preferred stock were issued and outstanding respectively. The preferred stock has preferential voting rights of 2000 votes per outstanding share. The Company has authorized 50,000 shares of Series B convertible preferred stock with a par value of $0.0001 per share. At December 31, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at December 31, 2016. The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at December 31, 2017. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock. During the quarter ended March 31, 2016, the Company issued an aggregate 4,787,129 shares of common stock at prices ranging from $0.00275 to $0.003355 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the quarter ended March 31, 2016, the Company issued 10,000 shares of Series B Preferred stock in settlement of the $50,000 liability to a related party for the purchase of inventory. During the quarter ended June 30, 2016, the Company issued an aggregate 10,683,804 shares of common stock at prices ranging from $0.0028 to $0.0044 per share as partial conversion of notes. During the quarter ended June 30, 2016 the Company amended a Convertible Debenture originally issued June 12, 2015. The Company issued 300,000 shares to the debenture holder for the main purpose of extending the maturity date to one year from the date of the amendment. During the quarter ended June 30, 2016, the Company issued 1,950,000 shares of common stock upon conversion of 3,900 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 1,100,000 shares of common stock upon conversion of 2,200 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the year ended December 31, 2017, the Company received additional paid-in-capital in the amount of $617,990 due to the conversion of debt which included the extinguishment of related derivatives. During the quarter ended June 30, 2016, the Company issued 4,000 shares of Series B Preferred stock in settlement of the $20,000 liability to a related party for the purchase of a trademark. On April 15, 2016 the Company entered into a Business Consulting Agreement with a Michigan limited liability company (“Consultant”). The agreement provides for the Company retaining the Consultant for 125 days for general business and product development services. The Consultant shall be paid $750 per month in cash and 500,000 shares of common stock of the Company valued at $5,000 as of the effective date and another 500,000 common shares upon determination of the Company in its sole and absolute discretion. During the quarter ended June 30, 2016 pursuant to the Business Consulting Agreement, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued an aggregate 39,043,730 shares of common stock at prices ranging from $0.0001 to $0.0092 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued an aggregate 13,500,000 shares of common stock at prices ranging from $0.0001 to $0.0092 per share for services provided to the Company. During the quarter ended December 31, 2016, the Company issued an aggregate 78,581,563 shares of common stock at prices ranging from $0.0012 to $0.0054 per share as partial conversion of notes. During the quarter ended December 31, 2016, the Company issued an aggregate 36,900,000 shares of common stock at prices ranging from $0.0012 to $0.0054 per share for services provided to the Company. During the quarter ended March 31, 2017, the Company issued an aggregate 43,000,000 shares of common stock at prices ranging from $0.0028 to $0.0094 per share for services provided to the Company. During the quarter ended March 31, 2017, the Company issued an aggregate 112,497,708 shares of common stock at prices ranging from $0.0001 to $0.0028 per share as partial conversion of notes. During the quarter ended March 31, 2017, the Company issued an aggregate 9,050,000 shares of common stock for conversion of 18,100 shares of Preferred Series B stock. During the quarter ended June 30, 2017, the Company issued an aggregate 33,000,000 shares of common stock at prices ranging from $0.0022 to $0.0028 per share for services provided to the Company. During the quarter ended June 30, 2017, the Company issued an aggregate 177,072,945 shares of common stock at prices ranging from $0.0001 to $0.0028 per share as partial conversion of notes and accrued interest. During the quarter ended June 30, 2017, the Company issued an aggregate 450,000 shares of Preferred Series A stock at par of $.0001. During the quarter ended September 30, 2017, the Company issued an aggregate 41,000,000 shares of common stock at prices ranging from $0.0002 to $0.0021 per share for services provided to the Company. During the quarter ended September 30, 2017, the Company issued an aggregate 62,196,454 shares of common stock at prices ranging from $0.00065 to $0.00099 per share as partial conversion of notes and accrued interest. During the quarter ended December 31, 2017, the Company issued an aggregate 71,000,000 shares of common stock at prices ranging from $0.0006 to $0.0011 per share for services provided to the Company. During the quarter ended December 31, 2017, the Company issued an aggregate 74,771,920 shares of common stock at prices ranging from $0.0004 to $0.0006 per share as partial conversion of notes and accrued interest.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 8. COMMITMENTS AND CONTINGENCIES The Company currently has three office locations. It rents offices on a month-to-month basis from the Company’s President and stockholder for $525 per month which amounted to $6,300 for the year ended December 31, 2017. The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment. The cost of this space for the year ended December 31, 2017 was $1,188. On September 12th 2016 the Company entered into a commercial lease agreement for office premises at an original cost of $650 per month for a one-year term with the option to renew for one extended term of three years. In July 2017 the Company leased additional space at this location thereby increasing the monthly rent to $1,450. The cost of this space for the year ended December 31, 2017 was $13,225. A new lease was signed in March 2018 for the same space. The following are the minimum required lease payments under the lease for the next four years: 2018- $ 17,200 2019- $ 24,600 2020- $ 24,600 2021- $ 4,100 The Company has agreements with consultants for ongoing services to be rendered with the following commitments: Commitment Term Consultant - FDA requirements and compliance $2,000 per month 12 Months Consultant - capital formation and market services Various equity percentage issuances of restricted stock for fundings 6 Months Consultant - tradeshow attendance, strategy and collaboration, coordination regarding FDA compliance, manufacturing operations, sales and marketing, other related services $10,000 per month (payable quarterly in cash or common stock from the 2016/2017 Equity Incentive Plan) 12 Months

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Taxes [Abstract]
INCOME TAXES	Note 9. INCOME TAXES On December 22, 2017, the President signed into law the Tax Cuts and Jobs Act (H.R. 1) (the “Act”). The Act includes a number of changes in existing tax law impacting businesses including, among other things, a permanent reduction in the corporate income tax rate from 34% to 21%. The rate reduction would take effect on January 1, 2018. The Company’s deferred tax asset consists primarily of carryforward net operating losses (NOLs). The Company believes that, at this time, it is more likely than not that the benefit of the NOLs will not be realized and has therefore recorded a full valuation allowance. The following represents the the NOLs incurred by the Company ona per year basis and the resulting estimated deferred tax asset and valuation allowance: Year Ended December 31, Net Operating Loss Estimated Deferred Tax Asset 2010 $ 4,457 $ 1,337 2011 34,325 $ 10,298 2012 174,024 $ 52,207 2013 114,267 $ 34,280 2014 294,880 $ 88,464 2015 121,619 $ 36,486 2016 382,095 $ 114,629 2017 1,148,020 $ 344,406 Total $ 2,273,687 $ 682,106 Less: Valuation Allowance $ (682,106 ) Net Deferred Tax Asset $ - The income tax benefit differs from the amount computed by applying the statutory federal and state income tax rates to the loss before income taxes. The sources and tax effects of the differences are as follows: December 31, 2017 December 31, 2016 Statutory federal income tax rate 21 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (30 )% (43 )% Effective income tax rate 0 % 0 % As of December 31, 2017, the Company has a net operating loss carryforward of approximately $2,273,687 to reduce future federal taxable income which begins to expire in the year 2030. The Company is also subject to corporate taxes in the State of New Jersey which has similar net operating loss carryover provisions which start to expire in the year 2030. Under the new Tax Cuts and Jobs Act (H.R. 1) (the “Act”), federal net operating losses generated after December 31, 2017can be carried forward indefinitely but only 80% of taxable income can be offset with a net-operating loss deduction. Net operating losses generated in years 2017 and prior may be fully utilized up to 100% of taxable income and they still maintain their 20-year carry-forward life. The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company’s open tax years beginning in tax year 2013 are subject to federal and state tax examinations.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Note 10. RELATED PARTY TRANSACTIONS In August 2015, the Company acquired 100% of the issued and outstanding common stock of Medical Lasers Manufacturer, Inc. (“MLM”) from a stockholder and officer of the Company for 20,000 common shares which were valued at $0.001 per share. All intercompany transactions were eliminated during consolidation. As more fully described in Note 3 to the Consolidated Financial Statements, the Company owed the following amounts to related parties as of the following: December 31 December 31, 2017 2016 Due to Related Party $ 8,921 $ 8,921 Due to officer/stockholder 8,398 10,555 Due to other stockholders 6,790 5,975 Total Related Party Obligations $ 24,109 $ 25,451 The company has entered into an employment agreement with its Chief Executive Officer (CEO) for the five year period beginning January 1, 2012. The agreement provides for base compensation, annual bonus, benefits, vacation and reimbursements. Under this agreement, the base compensation of the Company’s CEO is $100,000 per annum which has been accrued for the years ended December 31, 2015 and 2014. In mid-year 2016 the Company commenced payroll and is paying the CEO for current wages in this manner. During the year ended December 31, 2016, $18,974 in accrued compensation was paid. Accrued compensation in the amount of $30,000 was converted to shares of common stock during 2015. In the quarter ended June 30, 2017, $45 in accrued CEO compensation was converted to Series A Preferred shares. During the quarter ended September 30, 2017, $25,500 in accrued compensation was paid to the CEO. Effective October 1, 2017, the employment agreement between the Company and it’s CEO was amended to increase the annual salary to $150,000. During the quarter ended December 31, 2017 $44,673 in accrued compensation was paid to the CEO. In August 2015, MLM acquired a trademark from the son of the Company’s President for $20,000 due 90 days from the date of acquisition. During the quarter ended June 30, 2016, the Company issued 3,400 shares of Preferred Series B stock as settlement on this liability. Due to the uncertainty of future cash flows from the trademark management has deemed it to be impaired and recorded an impairment expense of $20,000 at September 30, 2015. In August 2015, subsequent to the date the Company acquired MLM, MLM purchased $50,000 in inventory from the son of the Company’s President. The inventory consisted of 20 hand-held laser devices. During the quarter-ended March 31, 2016, 10,000 shares of Series B Preferred stock were issued in settlement of this liability. In March 2017, the Company issued a promissory note to a related-party stockholder in the amount of $5,000 with interest at the rate of 9% per annum. The note matures on April 1, 2018. As of December 31, 2017 the entire $5,000 principal balance is outstanding on this note. As more fully described in Note 1-Intangible Asset-Licensing Agreement, on March 8th 2016 (with an effective date of October 1, 2015) the Company entered into a Licensing Agreement with a Florida Corporation (Licensor) that is owned by a related party. The Company issued 25,000 shares of Series B Preferred stock to the Licensor as partial consideration for the Licensing agreement plus a $150,000 promissory note to the Licensor for the balance of the consideration. During the quarter-ended March 31, 2016, 3,400 shares of Series B Preferred stock were converted into 1,700,000 shares of common stock in accordance with the terms of the Series B Preferred stock. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred stock was converted into 9,050,000 shares of common stock in accordance with the terms of the Series B Preferred stock. As more fully described in Note 1 and Note 5 to the financial statements, $18,986 in accrued interest on the $150,000 note was satisfied through the issuance of 17,272,727 shares of the Company’s common stock. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. At such time the Note was valued with it’s embedded derivative and discount. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000,000 shares of the Company’s common stock.

Basis of Reporting - Going Conc

Basis of Reporting - Going Concern	12 Months Ended
	Dec. 31, 2017
Basis of Reporting - Going Concern [Abstract]
BASIS OF REPORTING - GOING CONCERN	Note 11. BASIS OF REPORTING - GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $3,665,129 which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management’s plans to raise additional capital from the sale of stock and to receive additional financing and to commence sales of it’s flagship product and create revenue. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern. Management believes the Company’s present cash and cash equivalents will not enable it to continue to operate and meet its obligations for the coming twelve months from the date these financial statements are available to be issued unless the Company receives additional immediate funding.

Stock Compensation - Equity Inc

Stock Compensation - Equity Incentive Plan	12 Months Ended
	Dec. 31, 2017
Stock Compensation - Equity Incentive Plan [Abstract]
STOCK COMPENSATION - EQUITY INCENTIVE PLAN	Note 12. STOCK COMPENSATION - EQUITY INCENTIVE PLAN In July 2016, the Company adopted the Medifirst Solutions, Inc. 2016 Equity Incentive Plan (the “Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 20,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. On December 6th, 2016 the company amended the terms of the Plan and filed an S-8 Registration Statement with the Securities and Exchange Commission (“SEC”) increasing the number of shares permitted to be issued under the Plan to 32,000,000. During the quarter ended March 31, 2017, the Company issued from the Plan a total of 27,100,000 shares of common stock to non-employees for services rendered. As of March 31, 2017 there is a balance of -0- shares available for future issuance under the Medifirst Solutions, Inc. 2016 Equity Incentive Plan. In May 2017, the Company adopted the Medifirst Solutions, Inc. 2017 Equity Incentive Plan (the “Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 125,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. During the year ended December 31, 2017, the Company issued from the Plan 108,000,000 shares to non-employees for services rendered. As of December 31, 2017 there is a balance of 17,000,000 shares available for future issuance under the Medifirst Solutions, Inc. 2017 Equity Incentive Plan. In January 2018, the Company adopted the Medifirst Solutions, Inc. 2018 Equity Incentive Plan (the “Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 175,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 13. SUBSEQUENT EVENTS Subsequent to the year ended December 31, 2017, the Company issued an aggregate of 18,000,000 shares of Common Stock for services rendered by consultants and professionals. Subsequent to the year ended December 31, 2017, the Company issued an aggregate 376,111,255 shares of Common Stock upon conversions of an aggregate principal amount equal to $76,870 outstanding convertible promissory notes and $2,376 in accrued interest. On January 25. 2018, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of two 8% convertible notes in aggregate principal amount of $157,500. On January 25, 2018, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $78,750 (the “$78K Note”). Cash funding of $75,000 was received by the Company in February 2018 (after deducting $3,750 in legal fees). Under the Purchase Agreement, the Company and the Investor are expected to conduct an additional closing in the future for the sale and purchase of the additional note having the same terms as the Note in principal amount equal to $78,750 (the “back-end notes”). The Note that closed on January 25, 2018 matures and is payable on January 25, 2019.

Nature of Operations and Summ21

Nature of Operations and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
Organization	Organization Medifirst Solutions, Inc. (“MSI” or the “Company”) was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company’s products, developing the Company’s models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company’s offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. The company has started to hire a salesforce and sign distribution agreements in anticipation of future sales. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Company is actively putting together a sales and distribution team to offer our lasers in the US and foreign markets. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company’s president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. (“MLM”) with the total purchase price of 20,000 shares of the Company’s common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology.
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, all adjustments considered necessary for a fair presentation of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior year net income or shareholders’ equity.
Revenue Recognition	Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company’s historical return experience. Revenue is presented net of returns.
Accounts Receivable	Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management’s estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of December 31, 2017 or December 31, 2016. There are no customer account receivables as of December 31, 2017 or December 31, 2016.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Finished goods inventory includes hand held laser devices, their carrying cases and goggles.
Equipment	Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years.
Long-Lived Assets	Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company’s wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in 2015.
Intangible Asset- Licensing Agreement	Intangible Asset- Licensing Agreement On March 8 th - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. On September 15, 2017 the Note was amended to include provisions to allow conversion of the Note into common stock of the Company. On September 25, 2017, $16,250 in principal on this note was satisfied by the conversion into 25,000,000 shares of the Company’s common stock. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet since they are based on sales for which the company has had only minimum thus far. The licensing agreement is for a ten year period effective from October 1, 2015. The cost of the licensing agreement is being amortized over it’s ten-year period and charged to income on a straight-line basis.
Debt Issue Costs and Debt Discount	Debt Issue Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements).
Original Issue Discount	Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Derivative Liabilities	Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Financial Instruments	Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values.
Segment Information	Segment Information The Company follows Accounting Standards Codification (“ASC”) 280, “Segment Reporting”. The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. As of December 31, 2017, the convertible notes payable can be converted into approximately 1,039,477,572 shares of common stock.
Income Taxes	Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of December 31, 2017 and does not expect this to change significantly over the next 12 months.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At December 31, 2017, the Company had $287,569 in cash equivalents.
Recent Pronouncements	Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company to annual reporting periods beginning after December 15, 2017 (that is, a public organization is required to apply the new revenue standard beginning in the first interim period within the year of adoption). Additionally, the Board decided to permit public organizations to adopt the new revenue standard early, but not before the original public organization effective date (that is, annual periods beginning after December 15, 2016). A public organization should apply the new revenue standard to all interim reporting periods within the year of adoption. The Company has evaluated the impact of this ASU on the consolidated financial statements and has determined, at this time, the ASU’s implementation would not have a material impact on revenue recognition. See below - Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In April 2016, the FASB issued Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: 1. Identify the contract(s) with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when (or as) the entity satisfies a performance obligation. The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The Company is currently evaluating the impact of this ASU on the consolidated financial statements.

Property, Plant and Equipment22

Property, Plant and Equipment (Net) (Tables)	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment (Net) [Abstract]
Summary of equipment recorded at cost	December 31, 2017 December 31,2016 Computer equipment $ 8,956 $ 8,956 Less: accumulated depreciation (7,725 ) (7,085 ) $ 1,232 $ 1,871

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2017
Short-term Debt [Line Items]
Schedule of derivative liabilities	Remaining Original Deferred Total Convertible 12/31/2017 Principal Issue Derivative Financing Notes Derivative Debt Amount Discount Discount Costs Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - SD 15,000 15,000 Note Payable - NW 715 715 Note Payable - MC #2 890 890 Convertible Note Payable - JR (5%) 50,000 50,000 Convertible Note Payable - CB (5%) - - 832 Convertible Notes Payable- SO (8%) 25,452 25,452 24,925 Convertible Note Payable - LGC (8%) 1 94,400 (59,267 ) (317 ) 34,816 52,989 Convertible Note Payable - LGC (8%) 2 125,000 (83,380 ) (2,072 ) 39,548 64,458 Convertible Note Payable - LGC (8%) 3 125,000 (3,271 ) 121,729 Convertible Note Payable - LGC (8%) 4 125,000 (3,750 ) 121,250 Convertible Note Payable - MLM (10%) 133,750 (129,234 ) 4,516 108,682 $ 695,392 $ - $ (271,881 ) $ (9,410 ) $ 414,101 $ 251,886
Notes converted $110 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Principal Amount Converted Conversion Rate Shares Received Date of Conversion June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000
New note holder converted an additional $90 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000
New note holder converted an additional $90 one [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000
Note converted $1,010 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion	Principal Amount Converted Conversion Rate Shares Received Date of Conversion December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000

Derivatives and Fair Value In24

Derivatives and Fair Value Instruments (Tables)	12 Months Ended
	Dec. 31, 2017
Derivatives and Fair Value Instruments [Abstract]
Summary of projected annual volatility for each valuation period	9/30/2017 165 % 10/28/2017 142 % 11/2/2017 131 % 12/4/2017 132 % 12/18/2017 122 % 12/31/2017 125 %
Summary of derivative liabilities on convertible notes payable	12/31/2017 Convertible Note Derivative Treatment Maturity Date Principal Note Amount Original Derivative Valuation Derivative Valuation December 31, Quarter Ended March 31, 2017 Issuances Quarter Ended Derivative Valuation March 31, Quarter Quarter Ended Derivative Quarter Quarter Ended 2017 Mark-to-Market Derivative Quarter Quarter Ended Derivative 8% Convertible Note Payable- issued 5/2/2016 10/1/2016 5/2/2017 $ 57,750 $ 58,355 $ 58,355 - $ (34,680 ) $ 17,806 $ 41,481 $ - $ (14,925 ) $ 26,556 $ - $ - $ (821 ) $ 25,735 $ (810.00 ) $ 24,925 5% Convertible Notes Payable-issued 6/12/2015 4/12/2016 1/7/2017 35,863 37,827 918 440 $ 1,358 - (475 ) 883 (18 ) 865 $ (33.00 ) 832 9% Convertible Notes Payable-issued 10/01/2016 3/26/2017 3/27/2018 157,895 56,956 162,463 58,370 $ 220,833 (194,820 ) - (26,013 ) - - - 8% Convertible Notes Payable-issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 21,395 (136,759 ) 115,364 $ - - - - - - 8% Convertible Notes Payable-issued January 7, 2016 1/7/2016 1/7/2017 50,000 15,803 15,803 66,985 $ 82,788 (85,228 ) - 2,440 - - - 8% Convertible Notes Payable-issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 36,449 45,348 $ 81,797 (74,602 ) - (7,195 ) - - - 8% Convertible Notes Payable-issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 15,894 60,672 $ 76,566 (17,111 ) - (26,546 ) 32,909 (31,741 ) (1,168 ) - - 8% Convertible Notes Payable-issued May 1, 2016 10/28/2017 5/1/2018 131,250 103,294 - (28,820 ) 103,294 (21,485 ) 52,989 8% Convertible Notes Payable-issued June 7, 2016 12/4/2017 6/7/2018 125,000 90,596 - 90,596 (26,138 ) 64,458 10% Convertible Notes Payable-issued March 8, 2016 9/15/2017 9/8/2018 150,000 167,164 - (17,805 ) 167,164 3,120 152,479 $ (43,797.00 ) 108,682 $ 909,561 $ 786,935 $ 148,814 $ 162,463 $ (171,439 ) $ 364,985 $ 504,823 $ (371,761 ) $ - $ (72,714 ) $ 60,348 $ (49,546 ) $ 167,164 $ 1,113 $ 179,079 $ (28,820 ) $ 193,890 $ (92,263 ) $ 251,886
Summary of market fair value adjustment	Mark-to market fair value adjustment for the quarter ended March 31, 2017 $ 364,985 Mark-to market fair value adjustment for the quarter ended June 30, 2017 $ (72,714 ) Mark-to market fair value adjustment for the quarter ended September 30, 2017 $ 1,113 Mark-to market fair value adjustment for the quarter ended December 31, 2017 $ (92,263 ) Total mark-to market fair value adjustment for the year ended December 31, 2017 $ 201,121

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies [Abstract]
Schedule of minimum required lease payments	2018- $ 17,200 2019- $ 24,600 2020- $ 24,600 2021- $ 4,100
Schedule of agreements with consultants for ongoing services for commitments	Commitment Term Consultant - FDA requirements and compliance $2,000 per month 12 Months Consultant - capital formation and market services Various equity percentage issuances of restricted stock for fundings 6 Months Consultant - tradeshow attendance, strategy and collaboration, coordination regarding FDA compliance, manufacturing operations, sales and marketing, other related services $10,000 per month (payable quarterly in cash or common stock from the 2016/2017 Equity Incentive Plan) 12 Months

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Taxes [Abstract]
Summary of NOLs, estimated deferred tax asset and valuation allowance of tax	Year Ended December 31, Net Operating Loss Estimated Deferred Tax Asset 2010 $ 4,457 $ 1,337 2011 34,325 $ 10,298 2012 174,024 $ 52,207 2013 114,267 $ 34,280 2014 294,880 $ 88,464 2015 121,619 $ 36,486 2016 382,095 $ 114,629 2017 1,148,020 $ 344,406 Total $ 2,273,687 $ 682,106 Less: Valuation Allowance $ (682,106 ) Net Deferred Tax Asset $ -
Schedule of statutory federal and state income tax rates to the loss before income taxes	December 31, 2017 December 31, 2016 Statutory federal income tax rate 21 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (30 )% (43 )% Effective income tax rate 0 % 0 %

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
Summary of owed amounts to related parties	December 31 December 31, 2017 2016 Due to Related Party $ 8,921 $ 8,921 Due to officer/stockholder 8,398 10,555 Due to other stockholders 6,790 5,975 Total Related Party Obligations $ 24,109 $ 25,451

Nature of Operations and Summ28

Nature of Operations and Summary of Significant Accounting Policies (Details) - USD ($)	1 Months Ended			3 Months Ended		12 Months Ended
	Sep. 25, 2017	Aug. 31, 2015	Aug. 19, 2015	Dec. 31, 2017	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2017	Dec. 31, 2016	Feb. 29, 2016
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Cash equivalents				$ 287,569		$ 287,569				$ 165,017
Estimated useful lives of assets						5 years
Cost of licensing agreement is being amortized term period						10 years
Equity method investment, ownership percentage			100.00%	4.99%		4.99%
Fair value of acquired entity			$ 20
Total purchase price, per share			$ 0.001
Total purchase price of shares			20,000
Conversion of stock, shares				39,713,817
Acquired trademark		$ 20,000
Impairment expense		$ 20,000
Convertible notes payable to investor				$ 909,561		$ 909,561
Convertible notes payable converted into common stock						1,039,477,572
Series B Preferred Stock [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Issuance of series B preferred shares as part consideration for license agreement, shares						25,000
Conversion of stock, shares					1,700,000
Promissory Note [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Promissory note issued by company				$ 150,000		$ 150,000			$ 5,000		$ 7,000
Conversion of stock, shares	25,000,000
Convertible notes payable to investor	$ 16,250
Convertible notes payable converted into common stock							2,400,000	2,500,000

Property, Plant and Equipment29

Property, Plant and Equipment (Net) (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment (Net) [Abstract]
Computer equipment	$ 8,956	$ 8,956
Less: accumulated depreciation	(7,725)	(7,085)
Total	$ 1,232	$ 1,871

Property, Plant and Equipment30

Property, Plant and Equipment (Net) (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Property Plant and Equipment (Net) (Textual)
Depreciation expense	$ 640	$ 930

Due to Related Party (Details)

Due to Related Party (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Due to Related Party (Textual)
Due to related party	$ 8,921	$ 8,921

Loans Payable - Stockholders (D

Loans Payable - Stockholders (Details) - USD ($)	1 Months Ended		12 Months Ended
	Feb. 28, 2017	Dec. 31, 2012	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2017	Feb. 29, 2016	Apr. 30, 2014
Loans Payable - Stockholders (Textual)
Stockholder of Company advance			$ 0	$ 0
Loan			$ 8,398	8,398
Debt conversion convertible shares, subsequent to the year end			1,039,477,572
Loan balance			$ 100	100
Stockholder [Member]
Loans Payable - Stockholders (Textual)
Shareholder indebted amount			$ 1,000	$ 1,500
Interest rate			26.70%
Promissory note due date			Jan. 1, 2014
Investor and noteholder [Member]
Loans Payable - Stockholders (Textual)
Principal amount converted	$ 500
Debt conversion convertible shares, subsequent to the year end	5,000,000
Promissory note [Member]
Loans Payable - Stockholders (Textual)
Shareholder indebted amount		$ 5,000
Interest rate		10.00%					9.00%	6.00%
Promissory note due date		Jun. 2, 2013	Apr. 1, 2018
Conversion price per share									$ 0.0001
Principal amount converted					$ 2,400	$ 2,500
Debt conversion convertible shares, subsequent to the year end					2,400,000	2,500,000
Promissory note issued by company			$ 150,000				$ 5,000	$ 7,000
Principal balance outstanding			$ 5,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details)	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Summary of convertible note conversion detail
Shares Received	1,039,477,572
June 2013 [Member] | Notes converted $110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 70
Conversion Rate | $ / shares	$ 0.0001
Shares Received	700,000
August 2013 [Member] | Notes converted $110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received	400,000

Convertible Notes Payable (De34

Convertible Notes Payable (Details 1)	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Summary of convertible note conversion detail
Shares Received	1,039,477,572
November 2013 [Member] | An additional $90 of note [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received	400,000
December 2013 [Member] | An additional $90 of note [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 50
Conversion Rate | $ / shares	$ 0.0001
Shares Received	500,000

Convertible Notes Payable (De35

Convertible Notes Payable (Details 2)	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Summary of convertible note conversion detail
Shares Received	1,039,477,572
March 2014 [Member] | An additional $90 of note [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 50
Conversion Rate | $ / shares	$ 0.0001
Shares Received	500,000
April 2014 [Member] | An additional $90 of note [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 40
Conversion Rate | $ / shares	$ 0.0001
Shares Received	400,000

Convertible Notes Payable (De36

Convertible Notes Payable (Details 3)	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Summary of convertible note conversion detail
Shares Received	1,039,477,572
December 2012 [Member] | Note converted $1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 150
Conversion Rate | $ / shares	$ 0.001
Shares Received	150,000
January 2013 [Member] | Note converted $1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 660
Conversion Rate | $ / shares	$ 0.001
Shares Received	660,000
March 2013 [Member] | Note converted $1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted | $	$ 200
Conversion Rate | $ / shares	$ 0.001
Shares Received	200,000

Convertible Notes Payable (De37

Convertible Notes Payable (Details 4) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Short-term Debt [Line Items]
Remaining Principal Amount	$ 695,392
Original Issue Discount
Derivative Discount	(271,881)
Deferred Financing Costs	(9,410)
Total Convertible Notes Payable	280,351	$ 391,653
Derivative Liability	251,886	$ 144,792
Note Payable - BS [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125
Total Convertible Notes Payable	125
Note Payable - SF [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	60
Total Convertible Notes Payable	60
Note Payable - SD [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	15,000
Total Convertible Notes Payable	15,000
Note Payable - NW [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	715
Total Convertible Notes Payable	715
Note Payable - MC #2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	890
Total Convertible Notes Payable	890
Convertible Note Payable - JR (5%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	50,000
Total Convertible Notes Payable	50,000
Convertible Note Payable - CB (5%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount
Total Convertible Notes Payable
Derivative Liability	832
Convertible Notes Payable- SO (8%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	25,452
Total Convertible Notes Payable	25,452
Derivative Liability	24,925
Convertible Note Payable - LGC (8%) 1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	94,400
Derivative Discount	(59,267)
Deferred Financing Costs	(317)
Total Convertible Notes Payable	34,816
Derivative Liability	52,989
Convertible Note Payable - LGC (8%) 2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125,000
Derivative Discount	(83,380)
Deferred Financing Costs	(2,072)
Total Convertible Notes Payable	39,548
Derivative Liability	64,458
Convertible Note Payable - LGC (8%) 3 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125,000
Deferred Financing Costs	(3,271)
Total Convertible Notes Payable	121,729
Convertible Note Payable - LGC (8%) 4 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125,000
Deferred Financing Costs	(3,750)
Total Convertible Notes Payable	121,250
Convertible Note Payable - MLM (10%)
Short-term Debt [Line Items]
Remaining Principal Amount	133,750
Derivative Discount	(129,234)
Total Convertible Notes Payable	4,516
Derivative Liability	$ 108,682

Convertible Notes Payable (De38

Convertible Notes Payable (Details Textual) - USD ($)	1 Months Ended															12 Months Ended
	Apr. 30, 2017	Jan. 31, 2017	Aug. 31, 2016	Apr. 30, 2015	Oct. 31, 2014	Apr. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2013	Aug. 31, 2013	Jul. 31, 2013	May 31, 2012	Mar. 31, 2011	Dec. 31, 2017	Dec. 31, 2016
Convertible Notes Payable (Textual)
Principal amount transferred to shareholders/third party												$ 330
Amount of accrued interest transferred												$ 55
Converted shares of common stock																1,039,477,572
Remaining principal of note																$ 890	$ 3,000
6% convertible notes [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes															January 2,012
Interest rate on notes															6.00%
Issued aggregate principal amount															$ 800
Notes converted $110 [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock											1,000,000	50,000				1,100,000
Principal amount converted											$ 100	$ 5				$ 110
Notes converted $110 [Member] | Third Party [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock											350,000
Principal amount converted											$ 35
New note holder converted an additional $90 [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock						900,000	900,000	900,000	900,000
Principal amount converted						$ 90	$ 90	$ 90	$ 90
Remaining principal of note																$ 125
$240 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																9.99%	9.99%
Conversion price per share													$ 0.0006			$ 0.0001	$ 0.0001
Converted shares of common stock													400,000			84,858,757	22,562,213
Principal amount converted													$ 240
Remaining principal of note																$ 60	$ 60
$300 Note [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock													300,000
Principal amount converted													$ 300
Remaining principal of note													9,690
$400 Note [Member]
Convertible Notes Payable (Textual)
Conversion price per share										$ 0.001
Converted shares of common stock										400,000
Principal amount converted										$ 400
$1,100 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																9.99%	9.99%
Conversion price per share																$ 0.001	$ 0.001
Converted shares of common stock					1,100,000
Principal amount converted					$ 1,100
Issuance of common shares																84,858,757	22,562,213
$25,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes														November 2,012
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock														9.99%
Retired amount of notes													$ 14,000
Interest rate on notes														6.00%
Conversion price per share														$ 0.001
Converted shares of common stock														1,010,000
Principal amount converted														$ 1,010
Description of conversion of convertible notes														The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock.
Issued aggregate principal amount														$ 25,000
$3,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes				October 2,015
Converted shares of common stock	6,000,000	11,000,000	3,000,000													6,000,000
Principal amount converted	$ 410	$ 1,100	$ 3,000													$ 600
Remaining principal of note																$ 715	$ 715
Description of conversion of convertible notes				The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share.
Issued aggregate principal amount				$ 3,000
$4,475 Note [Member]
Convertible Notes Payable (Textual)
Principal amount transferred to shareholders/third party										$ 1,000
Conversion price per share												$ 0.001
Converted shares of common stock		4,190,480								700,000		700,000
Principal amount converted										$ 700		$ 700
Remaining principal of note		$ 2,075										$ 4,475

Convertible Notes Payable (De39

Convertible Notes Payable (Details Textual 1) - USD ($)	May 02, 2016	Oct. 08, 2015	Aug. 31, 2015	Jul. 31, 2015	Dec. 31, 2017	Jun. 12, 2015
Convertible Notes Payable (Textual)
Convertible notes payable, principal amount					$ 909,561
Original issue, discount
8% Convertible Notes Payable [Member]
Convertible Notes Payable (Textual)
Convertible notes payable, principal amount	$ 60,000	$ 31,000	$ 38,000	$ 59,000
Interest rate on notes	8.00%	8.00%	8.00%	8.00%
Promissory note due date	May 2, 2017	Oct. 8, 2016	Mar. 31, 2016	Mar. 31, 2016
Conversion date, description	Beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.	The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.
Original issue, discount		$ 1,500				$ 100,000

Convertible Notes Payable (De40

Convertible Notes Payable (Details Textual 2)

Aug. 02, 2017USD ($)$ / shares

Jun. 02, 2017USD ($)

Oct. 11, 2016USD ($)

May 02, 2016USD ($)

Jan. 13, 2016USD ($)TradingDay

Jan. 07, 2016USD ($)

Oct. 15, 2015USD ($)

Oct. 08, 2015USD ($)

Sep. 25, 2017USD ($)shares

Jun. 30, 2017USD ($)

May 31, 2017

May 01, 2017USD ($)

Apr. 30, 2017shares

Sep. 27, 2016USD ($)

May 31, 2016USD ($)

Aug. 31, 2015USD ($)

Jul. 31, 2015USD ($)

Jun. 30, 2015USD ($)

Dec. 31, 2017USD ($)shares

Jun. 30, 2017USD ($)shares

Mar. 31, 2017USD ($)shares

Dec. 31, 2017USD ($)shares

Dec. 31, 2016USD ($)

Jul. 31, 2016USD ($)

Jun. 30, 2016USD ($)

Jun. 15, 2016USD ($)

Mar. 15, 2016USD ($)

Jun. 12, 2015USD ($)

Convertible Notes Payable (Textual)

Loss on extinguishment of debt

$ (4,733)

Convertible notes payable converted into common stock | shares

1,039,477,572

Sale of convertible redeemable principal amount

$ 46,803

$ 50,000

$ 100,000

Original issue, discount

Convertible notes payable

280,351

280,351

391,653

Remaining principal of note

890

890

3,000

Convertible notes payable, principal amount

$ 909,561

909,561

Conversion of stock, shares | shares

39,713,817

Convertible Notes Payable-LG (9%) [Member]

Convertible Notes Payable (Textual)

Promissory note due date

Mar. 27, 2018

Conversion date, description

The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum.

Convertible notes payable

$ 34,816

34,816

Principal amount converted

$ 100,000

Convertible notes payable, principal amount

$ 50,000

94,400

$ 94,400

Convertible Notes Payable- BBCG (9%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

9.00%

Promissory note due date

May 27, 2018

Original issue debt discount

$ 7,895

Debt discounted rate, percentage

57.50%

Convertible notes payable, principal amount

$ 157,895

157,895

Convertible Notes Payable-LGC (8%) BEN [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

Promissory note due date

Jan. 7, 2017

Convertible notes payable converted into common stock | shares

50,000

Proceeds from discount on legal fees

$ 75,697

collateralized secured promissory note

$ 50,000

Beneficial ownership interest rate

9.99%

Common stock conversion of trading days | TradingDay

20

Remaining principal of note

$ 46,803

$ 46,803

Principal amount converted

16,000

Conversion price, description

Conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion.

Convertible notes payable, principal amount

$ 50

Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Sale of convertible redeemable principal amount

$ 1,012,500

Debt instrument convertible redeemable description

Pursuant to which the Investor agreed to pay the Company $131,250 and $375,000 on or before January 1, 2018, February 2, 2018, March 10, 2018 and April 7, 2018 respectively. These Notes (often referred to as "back-end Notes"), bear interest at the rate of 8% per annum.

Principal amount converted

21,500

Convertible notes payable, principal amount

$ 125,000

131,250

$ 131,250

$ 131,250

Conversion of stock, shares | shares

350,358,103

Convertible notes issued date

Dec. 4, 2017

Oct. 28, 2017

Purchase agreement, description

The Purchase Agreement, pursuant to which the Company issued to the Investor two convertible redeemable notes each in the principal amount of $125,000; Under the Purchase Agreement, on January 1, 2018, February 2, 2018, March 10 ,2018 and April 7, 2018 the Company and the Investor expected to conduct additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $131,250, $125,000, $125,000 and $125,000 respectively (the "back-end notes"). However, all these "back-end notes" were cancelled in early 2018 and will not fund.

Convertible Note Payable - JR (5%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

5.00%

Conversion price per share | $ / shares

$ 0.003

Convertible notes payable

$ 50,000

$ 50,000

Principal amount converted

$ 50,000

Convertible notes payable, principal amount

50,000

50,000

Convertible Notes Payable - MLM (10%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable

4,516

4,516

Convertible notes payable, principal amount

133,750

$ 133,750

January 1, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Sale of convertible redeemable principal amount

131,250

Remaining principal of note

131,250

February 2, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

125,000

March 10, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

125,000

April 07, 2018 [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Remaining principal of note

$ 125,000

$131K Note [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

Proceeds from discount on legal fees

$ 481,250

$ 481,250

collateralized secured promissory note

131,250

Deducting of legal fees

25,000

Convertible notes payable, principal amount

131,250

$125K Note [Member] | Convertible Notes Payable - LG Funding (8%) [Member]

Convertible Notes Payable (Textual)

collateralized secured promissory note

125,000

Convertible notes payable, principal amount

$ 125,000

Common Stock [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

62,067,838

Remaining principal of note

105,000

Investor [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

Promissory note due date

May 2, 2017

Jan. 7, 2016

Conversion date, description

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

Sale of convertible redeemable principal amount

$ 251,803

Debt instrument convertible redeemable description

(i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the "$105K Note"); and (ii) a convertible redeemable note in principal amount of $50,000 (the "$50K Note" and together with the $105K Note, the "Notes").

Beneficial ownership interest rate

9.99%

Note receivables

$ 50,000

46,803

Remaining principal of note

46,803

46,803

50,000

Principal amount converted

$ 105,000

Convertible notes payable, principal amount

$ 57,750

5% CONVERTIBLE NOTES PAYABLE

Convertible Notes Payable (Textual)

Interest rate on notes

5.00%

5.00%

Promissory note due date

Oct. 15, 2016

Dec. 31, 2015

Conversion date, description

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date.

Original issue debt discount

$ 5,000

Debt discounted rate, percentage

55.00%

Sale of convertible redeemable principal amount

60,000

Convertible notes payable

Remaining principal of note

100,000

100,000

100,000

$ 40,000

Replacement note amount

$ 50,000

Convertible notes payable, principal amount

$ 35,000

$ 35,000

$ 100,000

$ 35,000

Convertible Note Payable-SO-B (8%) (Original $60k) [Member]

Convertible Notes Payable (Textual)

Interest rate on notes

8.00%

8.00%

8.00%

8.00%

Promissory note due date

May 2, 2017

Oct. 8, 2016

Mar. 31, 2016

Mar. 31, 2016

Conversion date, description

Beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Original issue, discount

$ 1,500

$ 100,000

Convertible notes payable, principal amount

$ 60,000

$ 31,000

$ 38,000

$ 59,000

Convertible Note Payable-SO-B (8%) (Original $60k) [Member] | Investor [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

23,489,690

Remaining principal of note

$ 25,452

$ 25,452

$ 57,750

Principal amount converted

$ 32,298

Debenture Payable - (5%) B (Original $100K) [Member]

Convertible Notes Payable (Textual)

Loss on extinguishment of debt

$ 4,733

$ 4,733

Interest rate on notes

5.00%

Promissory note due date

Dec. 31, 2015

Conversion date, description

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. The remaining principal balance on the note at June 30, 2016 was $40,000 after a private sale of $60,000 in principal and deemed accrued interest on May 2, 2016 to another investor and the issuance of a replacement note by the Company

Remaining principal of note

40,000

Replacement note amount

$ 50,000

Convertible notes payable, principal amount

$ 100,000

Promissory Note [Member] | Convertible Notes Payable - MLM (10%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 16,250

Accrued interest

$ 18,986

$ 18,986

Common stock issued on fully satisfied issuance | shares

17,272,727

Conversion of stock, shares | shares

25,000,000

Issuance of series B preferred shares as part consideration for license agreement, shares | shares

25,000

Derivatives and Fair Value In41

Derivatives and Fair Value Instruments (Details)	12 Months Ended
	Dec. 31, 2017
9/30/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	165.00%
10/28/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	142.00%
11/2/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	131.00%
12/4/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	132.00%
12/18/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	122.00%
12/31/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	125.00%

Derivatives and Fair Value In42

Derivatives and Fair Value Instruments (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Summary of convertible notes payable
Principal Note Amount	$ 909,561
Original Derivative Valuation	786,935
Derivative Valuation	251,886	$ 144,792
Conversions
Mark-to-Market	(72,714)
Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	148,814
Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances	162,463
Conversions	(171,439)
Mark-to-Market	364,985
Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	504,823
Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions	(371,761)
Mark-to-Market	(72,714)
Derivative Valuation June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	60,348
Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances	167,164
Conversions	(49,546)
Mark-to-Market	1,113
Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	179,079
Quarter Ended December 2017 [Member]
Summary of convertible notes payable
Issuances	193,890
Conversions	(28,820)
Mark-to-Market	$ (92,263)
8% Convertible Note Payable-issued 5/2/2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Oct. 1, 2016
Maturity Date	May 2, 2017
Principal Note Amount	$ 57,750
Original Derivative Valuation	58,355
8% Convertible Note Payable-issued 5/2/2016 [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	58,355
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions	(34,680)
Mark-to-Market	17,806
8% Convertible Note Payable-issued 5/2/2016 [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	41,481
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	26,556
Issuances
Conversions
Mark-to-Market	(14,925)
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market	(821)
8% Convertible Note Payable-issued 5/2/2016 [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	25,735
8% Convertible Note Payable-issued 5/2/2016 [Member] | Quarter Ended December 2017 [Member]
Summary of convertible notes payable
Mark-to-Market	(810)
8% Convertible Note Payable-issued 5/2/2016 [Member] | Derivative Valuation December 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 24,925
5% Convertible Notes Payable-issued 6/12/2015 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Apr. 12, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 35,863
Original Derivative Valuation	37,827
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	918
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market	440
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	1,358
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	883
Issuances
Conversions
Mark-to-Market	(475)
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market	(18)
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	865
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Quarter Ended December 2017 [Member]
Summary of convertible notes payable
Mark-to-Market	(33)
5% Convertible Notes Payable-issued 6/12/2015 [Member] | Derivative Valuation December 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 832
9% Convertible Notes Payable-issued 10/01/2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Mar. 26, 2017
Maturity Date	Mar. 27, 2018
Principal Note Amount	$ 157,895
Original Derivative Valuation	56,956
9% Convertible Notes Payable-issued 10/01/2016 [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation
9% Convertible Notes Payable-issued 10/01/2016 [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances	162,463
Conversions
Mark-to-Market	58,370
9% Convertible Notes Payable-issued 10/01/2016 [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	220,833
9% Convertible Notes Payable-issued 10/01/2016 [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
Issuances
Conversions	(194,820)
Mark-to-Market	(26,013)
9% Convertible Notes Payable-issued 10/01/2016 [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market
9% Convertible Notes Payable-issued 10/01/2016 [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
8% Convertible Notes Payable-issued January 7, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Jan. 7, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 105,000
Original Derivative Valuation	87,287
8% Convertible Notes Payable-issued January 7, 2016 [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	21,395
8% Convertible Notes Payable-issued January 7, 2016 [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions	(136,759)
Mark-to-Market	115,364
8% Convertible Notes Payable-issued January 7, 2016 [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
8% Convertible Notes Payable-issued January 7, 2016 [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
Issuances
Conversions
Mark-to-Market
8% Convertible Notes Payable-issued January 7, 2016 [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market
8% Convertible Notes Payable-issued January 7, 2016 [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
8% Convertible Notes Payable-issued January 7, 2016 One [Member]
Summary of convertible notes payable
Derivative Treatment Date	Jan. 7, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 50,000
Original Derivative Valuation	15,803
8% Convertible Notes Payable-issued January 7, 2016 One [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	15,803
8% Convertible Notes Payable-issued January 7, 2016 One [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market	66,985
8% Convertible Notes Payable-issued January 7, 2016 One [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	82,788
8% Convertible Notes Payable-issued January 7, 2016 One [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
Issuances
Conversions	(85,228)
Mark-to-Market	2,440
8% Convertible Notes Payable-issued January 7, 2016 One [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market
8% Convertible Notes Payable-issued January 7, 2016 One [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
8% Convertible Notes Payable-issued March 7, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Mar. 7, 2016
Maturity Date	Mar. 7, 2017
Principal Note Amount	$ 50,000
Original Derivative Valuation	87,538
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	36,449
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market	45,348
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	81,797
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
Issuances
Conversions	(74,602)
Mark-to-Market	(7,195)
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
8% Convertible Notes Payable-issued March 7, 2016 One [Member]
Summary of convertible notes payable
Derivative Treatment Date	Mar. 7, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 46,803
Original Derivative Valuation	82,115
8% Convertible Notes Payable-issued March 7, 2016 One [Member] | Derivative Valuation December 2016 [Member]
Summary of convertible notes payable
Derivative Valuation	15,894
8% Convertible Notes Payable-issued March 7, 2016 One [Member] | Quarter Ended March 31, 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions
Mark-to-Market	60,672
8% Convertible Notes Payable-issued March 7, 2016 One [Member] | Derivative Valuation March 31, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	76,566
8% Convertible Notes Payable-issued March 7, 2016 One [Member] | Quarter Ended June 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	32,909
Issuances
Conversions	(17,111)
Mark-to-Market	(26,546)
8% Convertible Notes Payable-issued March 7, 2016 One [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances
Conversions	(31,741)
Mark-to-Market	(1,168)
8% Convertible Notes Payable-issued March 7, 2016 One [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation
10% Convertible Notes Payable-issued March 8, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Sep. 15, 2016
Maturity Date	Sep. 8, 2018
Principal Note Amount	$ 150,000
Original Derivative Valuation	167,164
Derivative Valuation	108,682
Mark-to-Market	(43,797)
10% Convertible Notes Payable-issued March 8, 2016 [Member] | Quarter Ended September 2017 [Member]
Summary of convertible notes payable
Issuances	167,164
Conversions	(17,805)
Mark-to-Market	3,120
10% Convertible Notes Payable-issued March 8, 2016 [Member] | Derivative Valuation September 30, 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 152,479
8% Convertible Notes Payable-issued May 1, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Oct. 28, 2017
Maturity Date	May 1, 2018
Principal Note Amount	$ 131,250
Original Derivative Valuation	103,294
8% Convertible Notes Payable-issued May 1, 2016 [Member] | Quarter Ended December 2017 [Member]
Summary of convertible notes payable
Issuances	103,294
Conversions	(28,820)
Mark-to-Market	(21,485)
8% Convertible Notes Payable-issued May 1, 2016 [Member] | Derivative Valuation December 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 52,989
8% Convertible Notes Payable-issued June 7, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Dec. 4, 2017
Maturity Date	Jun. 7, 2018
Principal Note Amount	$ 125,000
Original Derivative Valuation	90,596
8% Convertible Notes Payable-issued June 7, 2016 [Member] | Quarter Ended December 2017 [Member]
Summary of convertible notes payable
Issuances	90,596
Mark-to-Market	(26,138)
8% Convertible Notes Payable-issued June 7, 2016 [Member] | Derivative Valuation December 2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 64,458

Derivatives and Fair Value In43

Derivatives and Fair Value Instruments (Details 2)	12 Months Ended
	Dec. 31, 2017USD ($)
Derivative [Line Items]
Mark-to market fair value adjustment	$ (72,714)
Total mark-to market fair value adjustment	201,121
Mark-to market fair value adjustment for the quarter ended March 31, 2017 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	364,985
Mark-to market fair value adjustment for the quarter ended June 30, 2017 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	(72,714)
Mark-to market fair value adjustment for the quarter ended September 30, 2017 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	1,113
Mark-to market fair value adjustment for the quarter ended December 31, 2017 [Member]
Derivative [Line Items]
Mark-to market fair value adjustment	$ (92,263)

Derivatives and Fair Value In44

Derivatives and Fair Value Instruments (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Jun. 02, 2017	May 01, 2017	Oct. 01, 2016	Mar. 07, 2016	Jan. 07, 2016	Aug. 19, 2015	Jun. 25, 2015	Jun. 12, 2015
Derivatives and Fair Value Instruments (Textual)
Derivative, description	The stock price of $0.0015 decreased to $0.0006 in this period (basis for the variable conversion price) would fluctuate with the Company projected volatility; - An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; - Capital raising events (a single financing at 1 month from the valuation date) are a factor for the VV Convertible Note. The full reset events projected to occur based on future stock issuance (single event) resulting in a reset exercise price. - The monthly trading volume would average $569,722 (rounded) as of 12/31/2017 and would increase at 5% per month;ownership limits conversion across LG’s 6 notes based on 4.99% with shares outstanding increasing monthly by 1%. - The variable conversion price of 50% to 58% over 3 to 20 trading days would have effective rates of 42.38% to 52.78%; - The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default;
Description of embedded derivative	The Company's 5% convertible notes payable and 8% convertible notes payable and 9% convertible note payable issued to unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument.
Equity method investment, ownership percentage	4.99%						100.00%
Fair value adjustment ((income)/expense)	$ 201,121
Maximum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	165.00%
Variable conversion rate	58.00%
Derivatives trading period	20 days
Derivatives effective rate	52.78%
Minimum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	122.00%
Variable conversion rate	50.00%
Derivatives trading period	3 days
Derivatives effective rate	42.38%
5% Convertible Notes Payable issued June 12th 2015 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes									5.00%
5% Convertible Notes Payable issued June 12th 2015 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes									5.00%
8% Convertible Note payable issued June 25th 2015 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes								8.00%
8% Convertible Note payable issued June 25th 2015 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes								8.00%
8% Convertible Notes Payable issued January 7, 2016 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes						8.00%
8% Convertible Notes Payable issued January 7, 2016 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes						8.00%
8% Convertible Notes Payable issued March 7, 2016 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes					8.00%
8% Convertible Notes Payable issued March 7, 2016 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes					8.00%
9% Convertible Note payable issued October 1, 2016 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes				9.00%
9% Convertible Note payable issued October 1, 2016 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes				9.00%
8% Convertible Notes Payable issued May 1, 2017 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes			8.00%
8% Convertible Notes Payable issued June 2, 2017 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes		8.00%

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	Apr. 15, 2016	Mar. 31, 2017	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Stockholders' Equity (Textual)
Common stock, shares authorized					4,000,000,000	4,000,000,000
Common stock, par value					$ 0.0001	$ 0.0001
Common stock, shares outstanding					849,437,003	225,847,976
Common stock, shares issued					849,437,003	225,847,976
Convertible preferred, stock description					At December 31, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at December 31, 2016. The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at December 31, 2017. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Issuance of Series B Preferred shares as payment for inventory						$ 50,000
Common stock value					$ 84,946	22,586
Additional paid in capital from derivative liability on debt conversion					$ 617,991	$ 306,781
Consultant [Member]
Stockholders' Equity (Textual)
Common stock shares issued for services, subsequent to the year end	500,000
Common stock value	$ 5,000
Monthly cash payment to consultant	$ 750
Common shares issued upon determination of its sole and absolute discretion	500,000
March 31, 2016 [Member]
Stockholders' Equity (Textual)
Common stock, shares issued					4,787,129
March 31, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value					$ 0.00275
March 31, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value					$ 0.003355
March 31, 2016 One [Member]
Stockholders' Equity (Textual)
Common stock, shares issued					1,700,000
Stock issued during period shares issued for conversion of notes, shares					3,400
March 31, 2016 Two [Member]
Stockholders' Equity (Textual)
Preferred stock, shares issued					10,000
Issuance of Series B Preferred shares as payment for inventory					$ 50,000
June 30, 2016 [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares					1,950,000
Issuance of Series B preferred shares as payment for inventory, shares					3,900
Stock issued during period shares issued for conversion of notes, shares					10,683,804
Stock issued during period shares issued for debenture holder					300,000
June 30, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares					$ 0.0028
June 30, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares					$ 0.0044
June 30, 2016 One [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares					1,100,000
Issuance of Series B preferred shares as payment for inventory, shares					2,200
June 30, 2016 Two [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares					1,700,000
Issuance of Series B preferred shares as payment for inventory, shares					3,400
June 30, 2016 Three [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares					4,000
Issuance of Series B Preferred shares as payment for inventory					$ 20,000
June 30, 2016 Four [Member] | Consultant [Member]
Stockholders' Equity (Textual)
Common stock, par value					$ 0.01
Common stock shares issued for services, subsequent to the year end					500,000
Series A preferred stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized					1,000,000	1,000,000
Preferred stock, par value					$ 0.0001	$ 0.0001
Preferred stock, shares issued					500,000	500,000
Preferred stock, shares outstanding					50,000	50,000
Preferred stock has preferential voting rights					The preferred stock has preferential voting rights of 2000 votes per outstanding share.
Series B Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized					50,000	50,000
Preferred stock, par value					$ 0.0001	$ 0.0001
Preferred stock, shares issued					8,000	26,100
Preferred stock, shares outstanding					8,000	26,100
Series B preferred were converted into common stock in December 31, 2016					12,900
Issuance of series B preferred shares as part consideration for license agreement, shares					25,000
Issuance of common shares upon conversion of shares		18,100
Issuance of Series B Preferred shares as payment for inventory						$ 1
Issuance of Series B preferred shares as payment for inventory, shares			3,400	10,000

Stockholders' Equity (Details46

Stockholders' Equity (Details Textual 1) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001	$ 0.0001
September 30, 2016 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	39,043,730
September 30, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	$ 0.0001
September 30, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	$ 0.0092
September 30, 2016 Two [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	13,500,000
September 30, 2016 Two [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001
September 30, 2016 Two [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0092
December 31, 2016 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	78,581,563
December 31, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	$ 0.0012
December 31, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	$ 0.0054
December 31, 2016 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	36,900,000
December 31, 2016 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0012
December 31, 2016 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0054
March 31, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	43,000,000
March 31, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0028
March 31, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0094
March 31, 2017 One [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, shares	112,497,708
March 31, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	$ 0.0001
March 31, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of notes, per shares	$ 0.0028
March 31, 2017 Two [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	9,050,000
Stock issued during period shares issued for conversion of notes, shares	18,100
June 30, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	33,000,000
June 30, 2017 [Member] | Series A Preferred Stock [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001
Common stock issued for services, shares	450,000
June 30, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0022
June 30, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0028
June 30, 2017 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	177,072,945
June 30, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001
June 30, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0028
September 30, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	41,000,000
September 30, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0002
September 30, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0021
September 30, 2017 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	62,196,454
September 30, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.00065
September 30, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.00099
December 31, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	71,000,000
December 31, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0006
December 31, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0011
December 31, 2017 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	74,771,920
December 31, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0004
December 31, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0006

Commitments and Contingencies47

Commitments and Contingencies (Details)	Dec. 31, 2017USD ($)
Commitments and Contingencies [Abstract]
2,018	$ 17,200
2,019	24,600
2,020	24,600
2,021	$ 4,100

Commitments and Contingencies48

Commitments and Contingencies (Details 1)	12 Months Ended
	Dec. 31, 2017
Consultant - FDA requirements and compliance [Member]
Commitments And Contingencies [Line Items]
Commitment	$2,000 per month
Term	12 months
Consultant - capital formation and market services [Member]
Commitments And Contingencies [Line Items]
Commitment	Various equity percentage issuances of restricted stock for fundings
Term	6 months
Consultant - tradeshow attendance, strategy and collaboration, coordination regarding FDA compliance, manufacturing operations, sales and marketing, other related services [Member]
Commitments And Contingencies [Line Items]
Commitment	$10,000 per month (payable quarterly in cash or common stock from the 2016/2017 Equity Incentive Plan)
Term	12 months

Commitments and Contingencies49

Commitments and Contingencies (Details Textual) - USD ($)	Sep. 12, 2016	Jul. 31, 2017	Dec. 31, 2017	Dec. 31, 2016
Commitments and Contingencies (Textual)
Current office space rate per month			$ 6,300
Commitments, description		The Company leased additioanl space at this location thereby ncreasing the monthly rent to $1,450.	The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment.
Payments for rent			$ 13,225
Rent expense			13,225	$ 9,536
Office premises cost	$ 650
Lease agreement renewal term	3 years
Office premises cost term	1 year
Stockholder [Member]
Commitments and Contingencies (Textual)
Current office space rate per month			525
Payments for rent			$ 1,188

Income Taxes (Details)

Income Taxes (Details)	Dec. 31, 2017USD ($)
Operating Loss Carryforwards [Line Items]
Net Operating Loss	$ 2,273,687
Estimated Deferred Tax Asset	682,106
Less: Valuation Allowance	682,106
Net Deferred Tax Asset
2010 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	4,457
Estimated Deferred Tax Asset	1,337
2011 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	34,325
Estimated Deferred Tax Asset	10,298
2012 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	174,024
Estimated Deferred Tax Asset	52,207
2013 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	114,267
Estimated Deferred Tax Asset	34,280
2014 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	294,880
Estimated Deferred Tax Asset	88,464
2015 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	121,619
Estimated Deferred Tax Asset	36,486
2016 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	382,095
Estimated Deferred Tax Asset	114,629
2017 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Loss	1,148,020
Estimated Deferred Tax Asset	$ 344,406

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Abstract]
Statutory federal income tax rate	21.00%	34.00%
State income taxes, net of federal taxes	9.00%	9.00%
Valuation allowance	(30.00%)	(43.00%)
Effective income tax rate	0.00%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes (Textual)
Net operating loss carryforward	$ 2,273,687
Operating loss carryforward expiration period, description	Reduce future federal taxable income which begins to expire in the year 2030.
Federal or state tax examinations, description	The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company's open tax years beginning in tax year 2013 are subject to federal and state tax examinations.
Net operating loss carryover, expiration date	Dec. 31, 2030
Deferred tax assets net operating losses	$ 146,337	$ 484,037
Statutory federal income tax rate	21.00%	34.00%
Income taxes rates and years description	Under the new Tax Cuts and Jobs Act (H.R. 1) (the "Act"), federal net operating losses generated after December 31, 2017can be carried forward indefinitely but only 80% of taxable income can be offset with a net-operating loss deduction. Net operating losses generated in years 2017 and prior may be fully utilized up to 100% of taxable income and they still maintain their 20-year carry-forward life.
Maximum [Member]
Income Taxes (Textual)
Corporate income tax rate	34.00%	34.00%
Minimum [Member]
Income Taxes (Textual)
Corporate income tax rate	21.00%	21.00%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Owed amounts of related parties
Due to Related Party	$ 8,921	$ 8,921
Due to officer/stockholder	8,398	10,555
Due to other stockholders	6,790	5,975
Total Related Party Obligations	$ 24,109	$ 25,451

Related Party Transactions (D54

Related Party Transactions (Details Textual)	1 Months Ended					3 Months Ended					6 Months Ended	12 Months Ended
	Sep. 30, 2017USD ($)	Sep. 25, 2017USD ($)shares	Sep. 30, 2015USD ($)	Aug. 31, 2015USD ($)LaserDevices$ / sharesshares	Dec. 31, 2012	Dec. 31, 2017USD ($)shares	Jun. 30, 2017USD ($)	Mar. 31, 2017USD ($)shares	Jun. 30, 2016shares	Mar. 31, 2016shares	Jun. 30, 2017USD ($)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Feb. 29, 2016USD ($)	Aug. 19, 2015USD ($)
Related Party Transactions (Textual)
Accrued compensation													$ 18,974	$ 30,000
Fair value of acquired entity																	$ 20
Impairment expense			$ 20,000
Officer's base compensation												$ 112,500	$ 100,000
Accrued CEO compensation was converted to Series A Preferred shares							$ 45
Convertible notes payable to investor						$ 909,561						$ 909,561
Conversion of stock, shares | shares						39,713,817
Series B Preferred Stock [Member]
Related Party Transactions (Textual)
Issuance of series B preferred shares as part consideration for license agreement, shares | shares												25,000
Issuance of common shares upon conversion of shares | shares								18,100
Converted into shares of common stock | shares								9,050,000		3,400
Settlement of liability | shares									3,400	10,000
Conversion of stock, shares | shares										1,700,000
Promissory Note [Member]
Related Party Transactions (Textual)
Promissory note issued by company						$ 150,000		$ 5,000				$ 150,000				$ 7,000
Accrued interest							$ 18,986				$ 18,986
Common stock issued on fully satisfied issuance | shares											17,272,727
Convertible notes payable to investor		$ 16,250
Conversion of stock, shares | shares		25,000,000
Principal balance outstanding						5,000						$ 5,000
Interest rate					10.00%			9.00%								6.00%
Promissory note due date					Jun. 2, 2013							Apr. 1, 2018
Chief Executive Officer [Member]
Related Party Transactions (Textual)
Accrued compensation	$ 25,500					$ 44,673						$ 44,673
Officer's base compensation														$ 100,000	$ 100,000
Increase annual salary	$ 150,000
Medical Lasers Manufacturer, Inc. [Member]
Related Party Transactions (Textual)
Percentage of acquisition				100.00%
Common stock shares issued for acquisition | shares				20,000
Price per share | $ / shares				$ 0.001
Fair value of acquired entity				$ 20,000
Purchase of inventory				$ 50,000
Number of hand held devices | LaserDevices				20
Acquisition of MLM, description				MLM acquired a trademark from the son of the Company's President for $20,000 due 90 days from the date of acquisition.

Basis of Reporting - Going Co55

Basis of Reporting - Going Concern (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Basis of Reporting - Going Concern (Textual)
Losses from inception	$ (3,665,129)	$ (2,107,293)

Stock Compensation - Equity I56

Stock Compensation - Equity Incentive Plan (Details) - shares	Dec. 06, 2016	May 31, 2017	Jul. 31, 2016	Mar. 31, 2017	Dec. 31, 2017
2016 Equity Incentive Plan [Member]
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of shares of common stock			20,000,000
Common stock to non-employees for services rendered				27,100,000
Issuance of common shares	32,000,000			0
2017 Equity Incentive Plan [Member]
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of shares of common stock		125,000,000
Common stock to non-employees for services rendered					108,000,000
Issuance of common shares					17,000,000
2018 Equity Incentive Plan [Member]
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of shares of common stock					175,000,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	1 Months Ended		12 Months Ended
	Feb. 28, 2018	Jan. 25, 2018	Dec. 31, 2017
Subsequent Events (Textual)
Debt conversion convertible shares, subsequent to the year end			1,039,477,572
Consultants and professionals [Member]
Subsequent Events (Textual)
Common stock shares issued for services, subsequent to the year end			18,000,000
Convertible promissory note [Member]
Subsequent Events (Textual)
Debt conversion convertible shares, subsequent to the year end			376,111,255
Aggregate principal amount, subsequent to the year end			$ 76,870
Accrued interest, subsequent to the year end			$ 2,376
Subsequent Event [Member]
Subsequent Events (Textual)
Percentage of accredited investor		8.00%
Accredited investor principal amount		$ 157,500
Convertible redeemable note in principal amount		78,750
Cash funding		75,000
Legal fees	$ 3,750
Additional note principal amount		$ 78,750
Notes close, description		The Note that closed on January 25, 2018 matures and is payable on January 25, 2019.